CNBC interviews Jean-Pierre Garnier, chief of pharmaceutical giant GlaxoSmithKline, on the company's earnings decline from generic competition.

Shares of GlaxoSmithKline declined 0.9 percent as the London-listed pharmaceutical posted a drop in third-quarter profit Wednesday. Andy Pen...

...chief ...earnings ...dropped 25 percent to 1.92 billion euros ($2.87 billion) as investment earnings at the wholesale-banking and insurance units declined. Hele speaks with Bloomberg's Mark Barton ...

CNN's Charles Hodson talks with GlaxoSmithKline CEO Jean-Pierre Garnier about his company's recent drop in earnings.

...chief ...earnings dropped 58 percent, more than analysts estimated, hurt by investment losses and writedowns. Wynaendts speaks with with Bloomberg's Mark Barton, Judith Bogner and Ryan Chilcote ...

...chief ...earnings ...drop 30 percent in the year ending March 31, plans for growth in emerging markets and prospects for the alliance between Nissan and Renault SA, of which Ghosn is also CEO. ...